TrialThe Journal of clinical investigation2022

Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.

Nikolaj Pagh Kristensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.